Disease Steps for Multiple Sclerosis
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Normal0–0
- Mild disability1–1
- Moderate disability2–2
- Early cane3–3
The Disease Steps for Multiple Sclerosis calculates assessing MS disease progression based on patient's ambulatory ability. Key inputs include disease step. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Assesses MS disease progression based on patient's ambulatory ability
Clinical Indication
The Disease Steps for Multiple Sclerosis is indicated for bedside clinical practice to support Assesses MS disease progression based on patient's ambulatory ability. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.
Limitations & Contraindications
Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.
Clinical Pearls & Action Plan
Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: Can be used for therapeutic decision-making and monitoring treatment response.
Direct mapping of patient's ambulatory ability to corresponding Disease Steps category (0-6 or U for unclassifiable)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| disease_step | string | Yes | Patient's current disease step based on ambulatory ability assessment |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Normal | Normal function |
| 1–1 | Mild disability | Mild symptoms or signs |
| 2–2 | Moderate disability | Visible abnormality of gait |
| 3–3 | Early cane | Intermittent unilateral support |
| 4–4 | Late cane | Dependent on unilateral support |
| 5–5 | Bilateral support | Requires bilateral support |
| 6–6 | Wheelchair | Confined to wheelchair |
Evidence-Based References (EBM)
- Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology. 1995 Feb;45(2):251-5. doi: 10.1212/wnl.45.2.251.DOI: 10.1212/wnl.45.2.251
- Learmonth YC, Motl RW, Sandroff BM, Pula JH, Cadavid D. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol. 2013 Apr 25;13:37. doi: 10.1186/1471-2377-13-37.DOI: 10.1186/1471-2377-13-37
- Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler. 1999 Oct;5(5):349-54. doi: 10.1177/135245859900500508.DOI: 10.1177/135245859900500508